Achieve Life Sciences Quarterly Income Statement
NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
5.56-0.31 (-5.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Achieve Life Sciences revenue and earnings
Achieve Life Sciences reported a net loss of $12.1 million, compared with a loss of $14.4 million a year earlier. Diluted earnings per share came in at -$0.11.
Summary generated from market data by MetaCap's automated system. Methodology
Achieve Life Sciences income statement (quarterly)
| Quarter (USD) | Q3 20262026-09-30 | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development | — | — | — | — | 5.32M | 6.71M | 7.10M | 7.30M | 7.61M | 5.11M | 2.80M | 2.11M |
| Interest Expense | 258.00K | 277.00K | 274.00K | 251.00K | 192.00K | 191.00K | 185.00K | 197.00K | 366.00K | 804.00K | 813.00K | 787.00K |
| Other Income (Expense) | 8.43M | -56.38M | 295.00K | 69.00K | 251.00K | -155.00K | 67.00K | -170.00K | -46.00K | -30.00K | -512.00K | -1.09M |
| Net Income | -12.11M | -74.77M | -10.17M | -14.66M | -14.44M | -12.72M | -12.83M | -12.36M | -12.51M | -8.46M | -6.49M | -5.48M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -0.11 | -0.80 | -0.19 | -0.23 | -0.28 | -0.37 | -0.37 | -0.37 | -0.36 | -0.25 | -0.26 | -0.23 |
| EPS (Diluted) | -0.11 | -0.80 | -0.19 | -0.23 | -0.28 | -0.37 | -0.37 | -0.37 | -0.36 | -0.25 | -0.26 | -0.23 |
| Shares Outstanding (Basic) | 105.48M | 93.51M | 53.38M | — | 51.02M | 34.69M | 34.69M | — | 34.36M | 34.32M | 25.05M | — |
| Shares Outstanding (Diluted) | 105.48M | 93.51M | 53.38M | — | 51.02M | 34.69M | 34.69M | — | 34.36M | 34.32M | 25.05M | — |
This table shows 12 quarterly periods of Achieve Life Sciences's income statement, from Q3 2026 back to Q4 2023, across 13 line items including operating expenses, research & development, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow QUIT's reporting calendar. What is a income statement?